Point72 Hong Kong LTD Pulmonx Corp Call Options Transaction History
Point72 Hong Kong LTD
- $1.96 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding LUNG
# of Institutions
124Shares Held
30.8MCall Options Held
1.2KPut Options Held
1.2K-
Primecap Management CO Pasadena, CA5.74MShares$37.2 Million0.04% of portfolio
-
Black Rock Inc. New York, NY3.04MShares$19.7 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct2.72MShares$17.6 Million0.06% of portfolio
-
Morgan Stanley New York, NY2.65MShares$17.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.08MShares$13.5 Million0.0% of portfolio
About Pulmonx Corp
- Ticker LUNG
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,268,400
- Market Cap $242M
- Description
- Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...